The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury
Frontiers in Physiology - Switzerland
doi 10.3389/fphys.2018.00180
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 27, 2018
Authors
Publisher
Frontiers Media SA